Bioelectronics Corp (BIEL)

[Boricka]

If BIEL in fact has approval, obviously good news. However, it is tempered by the fact that Whealan is still steering the ship. If they get approval, it will move from the pathetic base he has created at .0007. If he wasn't as inept as he is, we would be moving from .0025-.0030, minimum. If he had not have blown the Boots, Kt Tape, Bayer and CVS deals, does anyone in their right mind believe we would be sitting at .0007?

The stock will not get the previous level of bounce because of the common knowledge he did not have the capacity to commercialize the Actipatch at the retail level. He certainly does not have the ability to do so in a hospital setting. Is there a partner who could do so? Undeniably, YES!! However, Whealan cannot make deals, in two years the sales of Recovery RX will mirror those of Actipatch if Whealan is still around.

Short story, realize you are dealing with a fool. Hope for the bounce, take profits, wait for him to stumble, buy back shares. Remember, the patent expires in 2023, you have a couple of years to trade his foolishness.